Literature DB >> 19217942

Soluble expression and one-step purification of a neurotoxin Huwentoxin-I in Escherichia coli.

Nanying Che1, Lili Wang, Yin Gao, Chengcai An.   

Abstract

Huwentoxin-I (HWTX-I) is a small 33-amino acid neurotoxin from the venom of the Chinese bird spider Ornithoctonus huwena. HWTX-I selectively blocks N-type voltage-sensitive calcium channels (N-VSCCs) and has great potential for clinical application as a novel analgesic without inducing drug tolerance. However, there are still many unsolved issues for this peptide, such as its clinical efficacy in analgesia, anesthesia, and even its potential role in drug rehabilitation. Therefore, large amounts of active recombinant HWTX-I are urgently needed. In this report, we describe a novel and efficient way to produce large amounts of the valuable form in Escherichia coli. HWTX-I was expressed in soluble form as an N-terminal intein fusion product. After affinity purification, a pH shift-induced self-cleavage of the intein released HWTX-I, resulting in a single-column purification of the target protein. The whole-cell patch clamp assay showed that purified HWTX-I has activity similar to another commercialized N-VSCC blocker omega-conotoxin MVIIA. Production of HWTX-I by this method has the major advantages of high efficiency and low cost.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217942     DOI: 10.1016/j.pep.2009.02.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Selective purification of recombinant neuroactive peptides using the flagellar type III secretion system.

Authors:  Hanna M Singer; Marc Erhardt; Andrew M Steiner; Min-Min Zhang; Doju Yoshikami; Grzegorz Bulaj; Baldomero M Olivera; Kelly T Hughes
Journal:  MBio       Date:  2012-05-29       Impact factor: 7.867

2.  Recombinant expression and in vitro characterisation of active Huwentoxin-IV.

Authors:  Isabelle Sermadiras; Jefferson Revell; John E Linley; Alan Sandercock; Peter Ravn
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

Review 3.  Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli.

Authors:  Yifeng Li
Journal:  Biotechnol Appl Biochem       Date:  2009-07-06       Impact factor: 2.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.